Genome & Company (KOSDAQ:314130)
South Korea
· Delayed Price · Currency is KRW
6,350.00
-160.00 (-2.46%)
At close: Apr 28, 2026
Genome & Company Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 221,570 | 238,384 | 85,207 | 176,209 | 245,897 | 468,827 | |
| Market Cap Growth | 211.26% | 179.77% | -51.64% | -28.34% | -47.55% | -55.28% | |
| Enterprise Value | 217,202 | 227,511 | 89,070 | 151,242 | 185,907 | 383,841 | |
| Last Close Price | 6350.00 | 6880.00 | 2750.00 | 6245.00 | 8725.00 | 17350.00 | |
| PS Ratio | 9.01 | 9.70 | 3.07 | 12.33 | 17.46 | 1038.96 | |
| PB Ratio | 1.93 | 2.08 | 0.86 | 1.55 | 1.63 | 4.13 | |
| P/TBV Ratio | 2.63 | 2.83 | 3.40 | 4.83 | 3.73 | 8.10 | |
| EV/Sales Ratio | 8.83 | 9.25 | 3.21 | 10.58 | 13.20 | 850.63 | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.32 | 0.23 | 0.04 | 0.06 | |
| Net Debt / Equity Ratio | -0.16 | -0.16 | -0.49 | -0.53 | -0.67 | -0.62 | |
| Net Debt / EBITDA Ratio | 0.79 | 0.79 | 2.92 | 1.28 | 2.09 | 2.10 | |
| Net Debt / FCF Ratio | 0.96 | 0.96 | 2.41 | 1.17 | 1.99 | 2.42 | |
| Asset Turnover | 0.17 | 0.17 | 0.18 | 0.09 | 0.09 | 0.00 | |
| Inventory Turnover | 1.90 | 1.90 | 2.59 | 3.53 | 4.76 | - | |
| Quick Ratio | 1.90 | 1.90 | 2.80 | 3.09 | 9.83 | 8.03 | |
| Current Ratio | 2.31 | 2.31 | 3.08 | 3.36 | 10.49 | 8.32 | |
| Return on Equity (ROE) | -7.20% | -7.20% | -25.26% | -38.36% | -43.15% | -31.51% | |
| Return on Assets (ROA) | -12.50% | -12.50% | -9.78% | -20.55% | -23.17% | -17.48% | |
| Return on Capital Employed (ROCE) | -23.90% | -23.90% | -20.60% | -41.40% | -35.50% | -28.30% | |
| Earnings Yield | -2.90% | -2.70% | -23.60% | -26.94% | -21.08% | -7.28% | |
| FCF Yield | -8.43% | -7.83% | -23.82% | -28.99% | -20.50% | -6.19% | |
| Buyback Yield / Dilution | -2.90% | -2.90% | -7.91% | -0.32% | -4.71% | -39.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.